Ji H - Search Results

1

RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.

Wang R, Hu H, Pan Y, Li Y, Ye T, Li C, Luo X, Wang L, Li H, Zhang Y, Li F, Lu Y, Lu Q, Xu J, Garfield D, Shen L, Ji H, Pao W, Sun Y, Chen H. Wang R, et al. Among authors: ji h. J Clin Oncol. 2012 Dec 10;30(35):4352-9. doi: 10.1200/JCO.2012.44.1477. Epub 2012 Nov 13. J Clin Oncol. 2012. PMID: 23150706

2

HLungDB: an integrated database of human lung cancer research.

Wang L, Xiong Y, Sun Y, Fang Z, Li L, Ji H, Shi T. Wang L, et al. Among authors: ji h. Nucleic Acids Res. 2010 Jan;38(Database issue):D665-9. doi: 10.1093/nar/gkp945. Epub 2009 Nov 9. Nucleic Acids Res. 2010. PMID: 19900972 Free PMC article.

3

Comparable rate of EGFR kinase domain mutation in lung adenocarcinomas from Chinese male and female never-smokers.

Sun YH, Fang R, Gao B, Han XK, Zhang JH, Pao W, Chen HQ, Ji HB. Sun YH, et al. Acta Pharmacol Sin. 2010 May;31(5):647-8. doi: 10.1038/aps.2010.43. Epub 2010 Apr 26. Acta Pharmacol Sin. 2010. PMID: 20418893 Free PMC article. No abstract available.

4

Spectrum of LKB1, EGFR, and KRAS mutations in chinese lung adenocarcinomas.

Gao B, Sun Y, Zhang J, Ren Y, Fang R, Han X, Shen L, Liu XY, Pao W, Chen H, Ji H. Gao B, et al. Among authors: ji h. J Thorac Oncol. 2010 Aug;5(8):1130-5. doi: 10.1097/JTO.0b013e3181e05016. J Thorac Oncol. 2010. PMID: 20559149 Free PMC article.

5

Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.

Sun Y, Ren Y, Fang Z, Li C, Fang R, Gao B, Han X, Tian W, Pao W, Chen H, Ji H. Sun Y, et al. Among authors: ji h. J Clin Oncol. 2010 Oct 20;28(30):4616-20. doi: 10.1200/JCO.2010.29.6038. Epub 2010 Sep 20. J Clin Oncol. 2010. PMID: 20855837 Free PMC article.

6

LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling.

Gao Y, Xiao Q, Ma H, Li L, Liu J, Feng Y, Fang Z, Wu J, Han X, Zhang J, Sun Y, Wu G, Padera R, Chen H, Wong KK, Ge G, Ji H. Gao Y, et al. Among authors: ji h. Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18892-7. doi: 10.1073/pnas.1004952107. Epub 2010 Oct 18. Proc Natl Acad Sci U S A. 2010. PMID: 20956321 Free PMC article.

7

Establishment and characterization of primary lung cancer cell lines from Chinese population.

Zheng C, Sun YH, Ye XL, Chen HQ, Ji HB. Zheng C, et al. Acta Pharmacol Sin. 2011 Mar;32(3):385-92. doi: 10.1038/aps.2010.214. Acta Pharmacol Sin. 2011. PMID: 21372829 Free PMC article.

8

Comprehensive analysis of epidermal growth factor receptor gene status in lung adenocarcinoma.

Li C, Sun Y, Fang Z, Han X, Fang R, Zhang Y, Pan Y, Zhang W, Ren Y, Ji H, Chen H. Li C, et al. Among authors: ji h. J Thorac Oncol. 2011 Jun;6(6):1016-21. doi: 10.1097/JTO.0b013e318215a4f2. J Thorac Oncol. 2011. PMID: 21532505 Free article.

9

Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma.

Girard N, Sima CS, Jackman DM, Sequist LV, Chen H, Yang JC, Ji H, Waltman B, Rosell R, Taron M, Zakowski MF, Ladanyi M, Riely G, Pao W. Girard N, et al. Among authors: ji h. Eur Respir J. 2012 Feb;39(2):366-72. doi: 10.1183/09031936.00010111. Epub 2011 Jul 20. Eur Respir J. 2012. PMID: 21778168 Free article.

10

Lung adenocarcinomas with HER2-activating mutations are associated with distinct clinical features and HER2/EGFR copy number gains.

Li C, Sun Y, Fang R, Han X, Luo X, Wang R, Pan Y, Hu H, Zhang Y, Pao W, Shen L, Ji H, Chen H. Li C, et al. Among authors: ji h. J Thorac Oncol. 2012 Jan;7(1):85-9. doi: 10.1097/JTO.0b013e318234f0a2. J Thorac Oncol. 2012. PMID: 22071781 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,724 results

Search Page

Filters